report-bg

Pericardial Patches Market

Analysis by Product Type (Autologous, Xenograft, and Synthetic); by Source (Porcine Patch, Bovine Patch, and Equine Patch); by Application (Cardiovascular Surgery, Dental Surgery, Ophthalmology, Abdominal Surgery, and Others); and by End User (Hospitals, Ambulatory Care Centers, Diagnostic Centers, and Others) – Global Supply & Demand Analysis & Opportunity Outlook 2023-2033

Buy Now
Report ID: 4589 | Published On: Feb 22, 2023
Request Free Sample Copy

Global Pericardial Patches Market Size, Forecast, and Trend Highlights Over 2023 - 2033

The global pericardial patches market is estimated to garner a revenue of ~USD 604 Million by the end of 2033 by growing at a CAGR of ~7% over the forecast period, i.e., 2023 – 2033. Further, the market generated a revenue of ~USD 312 Million in the year 2022. The growth of the market can be attributed primarily to the rising number of cardiac arrest and heart transplant procedures around the world which require surgical procedures which generates the need for pericardial patches. It was observed that each year, there are approximately 4500 cardiac transplants conducted around the world, despite the fact that there are an estimated 48,000 potential recipients for transplantation in the world.

Pericardial-Patches-Market-scope.

Pericardial patches are among the most common medical solutions for surgical procedures. For pediatric cardiac surgery reconstruction, autologous pericardial patches are commonly used. In addition to reducing infection rates, these patches reduce bleeding, increase tissue compatibility, seal defects, and provide durability. Moreover, the rise in the prevalence of chronic diseases, improvements in pericardial patch manufacturing and sterilization, increased use of soft tissue patches in surgeries, along with globally rising healthcare expenditure are other factors expected to drive global pericardial patches market growth during the forecast period. The Centers for Medicare & Medicaid Services published data showing that the US spent USD 4.1 trillion on healthcare services in 2020, representing 19.7% of the country's GDP.


Pericardial-Patches-Market-scope.
Get more information on this report: Request Sample PDF

Global Pericardial Patches Market: Key Insights
cscs

Base Year

2022

Forecast Year

2023-2033

CAGR

~7%

Base Year Market Size (2022)

~ USD 312 Million

Forecast Year Market Size (2033)

~ USD 604 Million

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)


Global Pericardial Patches Market: Growth Drivers and Challenges

Growth Drivers

  • Rising Number of Surgical Procedures Worldwide - A large number of surgical procedures are performed each day to replace, repair, or regenerate tissues that have been damaged by any severe disease. A bovine pericardial patch is commonly used in procedures such as cardiology, cataract surgery, gum surgery, and hernia surgery. The use of cardiac patches is one of the primary therapeutic solutions for surgical procedures. Thus, increasing rates of surgical procedures are expected to propel the demand for pericardial patches during the forecast period. For instance, approximately 300 million major surgeries are performed worldwide every year, of which approximately 45 million are performed in the United States and 22 million in Europe.

  • Rise in Number of Eye Surgeries Performed Annually – Burgeoning geriatric population has led to a high number of eye surgeries such as cataract operations, glaucoma surgeries, corneal transplants, and others. The high number of eye operations around the world has led to an increased demand for pericardial patches in the next few years. It was observed that more than 9 million cataract operations are performed annually, ranging between 98 and 5000 per million people across the world.

  • Technologically Advanced and Innovative Product Development - The XenoSure Biologic Patch, introduced by LeMaitre Vascular, Inc., contains bovine pericardium, which is used for endovascular and arterial reconstruction surgeries.

  • Surge in Exports of Artificial Components of the Body -According to the statistics by the International Trade Center (Trademap), the value of exports of artificial parts of the body in the United States in the year 2021 was recorded to be USD 3,040,652 thousand which was an increase from USD 2,565,065 thousand in the previous year.

  • Globally Rising Per Capita Income - With the rapidly expanding economies, the per capita income of the population is also increasing. As a result, individuals have more spending capacity to invest in their treatment procedures by using modern medical products such as pericardial patches. Hence, pericardial patches become easily accessible with high-income levels which in turn is projected to expand the market size in the forecast period. According to data provided by the World Bank, the annual income of each individual in the world rose by 4.8% in 2021 from 1.5% in 2019.

Challenges

  • High Cost of Procedures Such as Cardiovascular Surgery, Orthopedic Surgery, and Other Surgeries – Although chronic and other diseases are increasing in every reason of the world, the cost of the diagnostic and treatment procedures of these diseases are proposing a threat to the middle-income population. As a result, the usage of pericardial patches in these treatments is also anticipated to lower during the assessment period.
  • Insufficient Supply of Grafts
  • Increased Risk of Infections


Global Pericardial Patches Market Segmentation

The global pericardial patches market is segmented and analyzed for demand and supply by application into cardiovascular surgery, dental surgery, ophthalmology, abdominal surgery, and others. Among these segments, the cardiovascular surgery segment is anticipated to capture the largest market size in the global pericardial patches market owing to the increasing number of cardiovascular surgeries performed in hospitals as a result of growing cardiovascular disease cases in the world. For instance, there are more than 890,000 cardiac surgery procedures performed each year in the United States. In cardiac surgery, pericardial patches are used to reconstruct the aorta and pulmonary vessels, close interatrial defects and reconstruct atrioventricular valves.

The global pericardial patches market is also segmented and analyzed for demand and supply by end-user into hospitals, ambulatory care centers, diagnostic centers, and others. Out of these, the hospital segment is attributed to garner the highest segment share by the end of the analysis period. The high number of surgical procedures occurring in hospital settings is considered to be the major factor contributing to the growth of segment growth. Other factors providing an impetus for segment growth are the growing proportion of hospitals around the world and the large number of anterior cruciate ligament repair procedures performed in hospitals across the globe. Furthermore, the massive investment made towards improving hospital infrastructure and favorable reimbursement policies of hospitals is also anticipated to bring profitable opportunities for the expansion of segment size by the end of the forecast period

Our in-depth analysis of the global pericardial patches market includes the following segments:

                  By Product Type

  • Autologous
  • Xenograft
  • Synthetic

                 By Source

  • Porcine Patch
  • Bovine Patch
  • Equine Patch

                By Application

  • Cardiovascular Surgery
  • Dental Surgery
  • Ophthalmology
  • Abdominal Surgery
  • Others

              By End User

  • Hospitals
  • Ambulatory Care Centers
  • Diagnostic Centers
  • Others


Global Pericardial Patches Market Regional Synopsis

The North America pericardial patches market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2033. The growth of the market can be attributed majorly to the rising incidence of anterior cruciate ligament (ACL) injuries and the availability of soft tissue allografts manufacturers in the region is expected to drive the pericardial patches market in the region. For instance, in the United States, ACL injuries and tears are among the most common knee injuries, with an estimated 150,000 to 200,000 of these injuries occurring each year. Further, the strong healthcare network in the region, along with the increased healthcare expenditure by the population is anticipated to promote the usage of pericardial patches in the upcoming years. Moreover, the rising focus on developing advanced pericardial patches by the market players is also anticipated to increase the awareness level of pericardial patches among medical professionals and the general population. In addition, the region's expanding healthcare industry and rising commercialization of pericardial patches are also anticipated to boost market growth during the forecast period.

Pericardial-Patches-Market-Regional.

Pericardial-Patches-Market-Regional.
Get more information on this report: Request Sample PDF

Top Featured Companies Dominating the Global Pericardial Patches Market

    • Edwards Lifesciences Corporation
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Visionary Medtech Solutions
    • Abbott Laboratories
    • CryoLife, Inc.
    • LeMaitre Vascular, Inc.
    • Neovasc, Inc.
    • FOC Medical
    • W. L. Gore & Associates, Inc.
    • Baxter International Inc.
    • Collagen Solutions Plc 

     


In The News

  • April 2022: IBSRELA the first and only NHE3 inhibitor for the treatment of irritable bowel syndrome with constipation (IBS-C) in adults, has been made available by the biopharmaceutical company Ardelyx. The first Ardelyx product to receive approval from the US Food and Drug Administration is IBSRELA.
  • March 2022: Indegene a provider of technology-driven healthcare solutions, & meta Me Health, a maker of Regulora and a Prescription Digital Therapeutics (PDT) business, teamed up to offer Regulora as a remedy for irritable bowel syndrome-related stomach pain (IBS).

Global Economic Impact

Request Insights
Despite Inflation & Fearing Recession, Businesses Across the Globe Expected to Do Better in 2023:

In 2023, market players might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain.
Controlling Inflation has become the first priority for global economies from last quarter of 2022 and to be followed in 2023. With skewed economic situations, rise in interest rate by governments to control spending and inflation, spiked oil and gas prices, high inflation, geo-political issues including U.S. & China trade war, Russia-Ukraine conflict to intensify the global economic issues.
The interest rates in the U.S. may be less sensitive in 2023 as compared to 2022; sigh of relief for businesses. Positive business sentiments, healthy business balance sheets, growth in construction spending (private construction value in 2022 stood at $1,429.2 billion, 11.7 percent (±1.0 percent) above the $1,279.5 billion spent in 2021, Residential construction in 2022 was $899.1 billion, up by 13.3 percent (±2.1 percent) from $793.7 billion in 2021, non-residential construction touched $530.1 billion, 9.1 percent (±1.0 percent) above the $485.8 billion in 2021.) showcases minimal impact of recession in the country.
Similarly, spiked spending in the European and major Asia economics including, India, China & Japan to showcase less impact on the global demand.

Key Questions Answered in the Report

1) What are the major factors driving the growth of the pericardial patches market?

Ans: The rise in the prevalence of chronic diseases, improvements in pericardial patch manufacturing and sterilization, and increased use of soft tissue patches in surgeries are the major factors driving the growth of the pericardial patches market.

2) What would be the CAGR of pericardial patches market over the forecast period?

Ans: The market is anticipated to attain a CAGR of ~7% over the forecast period, i.e., 2023 – 2033

3) What are the challenges affecting the pericardial patches market growth?

Ans: Insufficient supply of grafts and increased risk of infections along with the high costs of medical products are estimated to be the growth hindering factors for the market expansion.

4) Which region will provide more business opportunities for growth of pericardial patches market in future?

Ans: The market in the North America region is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.

5) Who are the major players dominating the pericardial patches market?

Ans: The major players in the market are Edwards Lifesciences Corporation, Visionary Medtech Solutions, Abbott Laboratories, CryoLife, Inc., LeMaitre Vascular, Inc., Neovasc, Inc., FOC Medical, W. L. Gore & Associates, Inc., and others.

6) How are the company profiles selected?

Ans: The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

7) What are the segments in the pericardial patches market?

Ans: The market is segmented by product type, source, application, end user, and by region.

8) Which segment captures the largest market size in application segment in the pericardial patches market?

Ans: The cardiovascular surgery segment is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.

Let Us Hear About Your Requirements:

Submit Your Request For Proposal (RFP)

Request Research Report Sample